These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9513658)

  • 21. Demonstration of bronchial eosinophil activity in seasonal allergic rhinitis by induced plasma exudation combined with induced sputum.
    Greiff L; Andersson M; Svensson C; Linden M; Wollmer P; Persson CG
    Thorax; 1999 Jan; 54(1):33-6. PubMed ID: 10343628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of nasal hyper-reactivity.
    Andersson M; Greiff L; Svensson C; Persson C
    Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1(Suppl 1):S22-6. PubMed ID: 7734972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo.
    Greiff L; Andersson M; Wollmer P; Persson CG
    Eur Respir J; 2003 Feb; 21(2):308-12. PubMed ID: 12608446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma exudation in tracheobronchial and nasal airways: a mucosal defence mechanism becomes pathogenic in asthma and rhinitis.
    Persson CG
    Eur Respir J Suppl; 1990 Dec; 12():652s-656s; discussion 656s-657s. PubMed ID: 2076159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma exudation as a first line respiratory mucosal defence.
    Persson CG; Erjefält I; Alkner U; Baumgarten C; Greiff L; Gustafsson B; Luts A; Pipkorn U; Sundler F; Svensson C
    Clin Exp Allergy; 1991 Jan; 21(1):17-24. PubMed ID: 2021873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption of 51Cr EDTA across the human nasal airway barriers in the presence of topical histamine.
    Greiff L; Wollmer P; Pipkorn U; Persson CG
    Thorax; 1991 Sep; 46(9):630-2. PubMed ID: 1948790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions.
    Greiff L; Pipkorn U; Alkner U; Persson CG
    Clin Exp Allergy; 1990 May; 20(3):253-9. PubMed ID: 2364306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma extravasation through neuronal stimulation in human nasal mucosa in the setting of allergic rhinitis.
    Sanico AM; Atsuta S; Proud D; Togias A
    J Appl Physiol (1985); 1998 Feb; 84(2):537-43. PubMed ID: 9475863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease.
    Turner PJ; Foreman JC
    Mediators Inflamm; 1999; 8(3):133-46. PubMed ID: 10704051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways.
    Svensson C; Baumgarten CR; Pipkorn U; Alkner U; Persson CG
    Thorax; 1989 Jan; 44(1):13-8. PubMed ID: 2648641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hydrogen peroxide on the guinea-pig tracheobronchial mucosa in vivo.
    Greiff L; Erjefält I; Erjefält JS; Wollmer P; Persson CG
    Acta Physiol Scand; 1999 Apr; 165(4):415-20. PubMed ID: 10350237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of eosinophils in the early-phase allergic reaction in a guinea pig rhinitis model.
    Imai N; Miyahara A; Yamazaki Y; Homma R; Ino Y; Kurumi M
    Int Arch Allergy Immunol; 2000 Aug; 122(4):270-8. PubMed ID: 10971118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histamine-induced airway mucosal exudation of bulk plasma and plasma-derived mediators is not inhibited by intravenous bronchodilators.
    Svensson C; Alkner U; Pipkorn U; Persson CG
    Eur J Clin Pharmacol; 1994; 46(1):59-65. PubMed ID: 8005188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal and bronchial responses to flour-inhalation in subjects with occupationally induced allergy affecting the airway.
    Górski P; Krakowiak A; Ruta U
    Int Arch Occup Environ Health; 2000 Sep; 73(7):488-97. PubMed ID: 11057418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma exudation and solute absorption across the airway mucosa.
    Greiff L; Erjefält I; Svensson C; Wollmer P; Alkner U; Andersson M; Persson CG
    Clin Physiol; 1993 May; 13(3):219-33. PubMed ID: 8519158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
    Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
    Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiallergic actions of high topical doses of terbutaline in human nasal airways.
    Svensson C; Greiff L; Andersson M; Alkner U; Grönneberg R; Persson CG
    Allergy; 1995 Nov; 50(11):884-90. PubMed ID: 8748720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upper and lower airway pathology in young children with allergic- and non-allergic rhinitis.
    Chawes BL
    Dan Med Bull; 2011 May; 58(5):B4278. PubMed ID: 21535990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal exudation of fibrinogen in coronavirus-induced common colds.
    Akerlund A; Greiff L; Andersson M; Bende M; Alkner U; Persson CG
    Acta Otolaryngol; 1993 Sep; 113(5):642-8. PubMed ID: 8266793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA.
    Greiff L; Wollmer P; Svensson C; Andersson M; Persson CG
    Thorax; 1993 Jun; 48(6):648-50. PubMed ID: 8346497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.